share_log

NuScale Power Analyst Ratings

Benzinga ·  Aug 17, 2023 07:57
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/17/2023 28.94% Wells Fargo $12.5 → $9 Maintains Equal-Weight
03/22/2023 107.74% TD Cowen $17 → $14.5 Maintains Outperform
10/25/2022 86.25% UBS → $13 Initiates Coverage On → Neutral
08/25/2022 143.55% Wells Fargo → $17 Initiates Coverage On → Equal-Weight
08/18/2022 157.88% Guggenheim → $18 Initiates Coverage On → Buy
05/13/2022 114.9% Cowen & Co. → $15 Initiates Coverage On → Outperform

What is the target price for NuScale Power (SMR)?

The latest price target for NuScale Power (NYSE: SMR) was reported by Wells Fargo on August 17, 2023. The analyst firm set a price target for $9.00 expecting SMR to rise to within 12 months (a possible 28.94% upside). 5 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for NuScale Power (SMR)?

The latest analyst rating for NuScale Power (NYSE: SMR) was provided by Wells Fargo, and NuScale Power maintained their equal-weight rating.

When is the next analyst rating going to be posted or updated for NuScale Power (SMR)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NuScale Power, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NuScale Power was filed on August 17, 2023 so you should expect the next rating to be made available sometime around August 17, 2024.

Is the Analyst Rating NuScale Power (SMR) correct?

While ratings are subjective and will change, the latest NuScale Power (SMR) rating was a maintained with a price target of $12.50 to $9.00. The current price NuScale Power (SMR) is trading at is $6.98, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment